Avricore Health Inc. Research And Development Expense

Quick Answer

Avricore Health Inc. reported Research And Development Expense of $251.5 thousand for the year ending 2018.

  • Avricore Health Inc. showed an increase of +3.8% in Research And Development Expense from 2017 to 2018.
  • This data is from Avricore Health Inc.'s annual report (Form 10-K), filed with the SEC on June 17, 2019.
  • XBRL data for this metric is available from 2016 to 2018 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2016 to 2018), Avricore Health Inc.'s Research And Development Expense has grown by 20.5%.
  • Historical annual values: Fiscal year 2018: $251.5 thousand | Fiscal year 2017: $242.3 thousand | Fiscal year 2016: $208.8 thousand.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: